Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Teladoc Inc

Healthcare US TDOC

5.57USD
0.27(5.09%)

Last update at 2026-03-10T20:16:00Z

Day Range

5.486.09
LowHigh

52 Week Range

15.0234.36
LowHigh

Fundamentals

  • Previous Close 5.30
  • Market Cap3615.76M
  • Volume15171706
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA23.03M
  • Revenue TTM2579.60M
  • Revenue Per Share TTM15.77
  • Gross Profit TTM 1662.85M
  • Diluted EPS TTM-24.68

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -13663.34300M -384.65600M -575.99300M -109.45500M -96.96600M
Minority interest - - - - -
Net income -13659.53100M -428.79300M -485.13600M -98.86400M -97.08400M
Selling general administrative 449.86M 438.01M 506.68M 164.46M 118.78M
Selling and marketing expenses 850.71M 667.31M 380.20M 174.61M 144.26M
Gross profit 1662.85M 1382.45M 703.13M 368.84M 289.17M
Reconciled depreciation 270.64M 219.62M 78.09M 44.95M 35.60M
Ebit -13739.76800M -238.98800M -418.18500M -73.82200M -65.96300M
Ebitda -13469.12500M -14.27900M -340.09800M -28.87000M -30.36100M
Depreciation and amortization 270.64M 224.71M 78.09M 44.95M 35.60M
Non operating income net other -0.85900M -38.66000M -9.07700M - -
Operating income -13198.48200M -238.98800M -418.18500M -73.82200M -70.85400M
Other operating expenses 2634.21M 2271.70M 1512.15M 627.13M 483.87M
Interest expense 9.27M 80.36M 60.49M 29.01M 26.11M
Tax provision -3.81200M 44.14M -90.85700M -10.59100M 0.12M
Interest income - - - 29.01M 26.11M
Net interest income -9.27000M -80.36500M -60.49500M -29.01300M -26.11200M
Extraordinary items - - - - -
Non recurring 13425.85M 26.64M 88.24M 6.62M 12.26M
Other items - - - - -
Income tax expense -3.81200M 44.14M -90.85700M -10.59100M 0.12M
Total revenue 2406.84M 2032.71M 1093.96M 553.31M 417.91M
Total operating expenses 1890.22M 1621.44M 1121.32M 442.66M 355.13M
Cost of revenue 743.99M 650.26M 390.83M 184.47M 128.74M
Total other income expense net -26861.82500M -145.66800M -157.80800M -35.63300M -4.89100M
Discontinued operations - - - - -
Net income from continuing ops -13659.53100M -428.79300M -485.13600M -98.86400M -97.08400M
Net income applicable to common shares -13659.53100M -428.79300M -485.13600M -98.86400M -97.08400M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 4345.35M 17734.61M 17755.28M 1602.83M 1528.88M
Intangible assets 1836.77M 1910.28M 2020.86M 225.45M 247.39M
Earning assets - - - - -
Other current assets 130.31M 87.39M 47.26M 13.99M 10.63M
Total liab 2037.61M 1688.85M 1871.48M 588.80M 515.76M
Total stockholder equity 2307.74M 16045.76M 15883.80M 1014.02M 1013.12M
Deferred long term liab 54.81M 2.40M 104.55M 21.68M 32.44M
Other current liab 248.03M 195.50M 191.70M 63.55M 44.41M
Common stock 0.16M 0.16M 0.15M 0.07M 0.07M
Capital stock 0.16M 0.16M 0.15M 0.07M 0.07M
Retained earnings -15008.28700M -1421.45400M -992.66100M -507.52500M -408.66100M
Other liab 56.43M 81.10M 106.17M 33.22M 38.63M
Good will 1073.19M 14504.17M 14581.25M 746.08M 737.20M
Other assets 48.54M 20.70M 0.00209M 6.54M 1.40M
Cash 918.18M 893.48M 733.32M 514.35M 423.99M
Cash and equivalents - - - - -
Total current liabilities 399.77M 331.01M 332.65M 90.18M 62.44M
Current deferred revenue 90.46M 75.57M 52.36M 12.47M 7.65M
Net debt 655.15M 373.96M 731.97M -48.94900M -9.30600M
Short term debt 13.59M 12.69M 42.56M 5.09M 2.61M
Short long term debt - - 42.56M - -
Short long term debt total 1573.33M 1267.44M 1465.29M 465.40M 414.68M
Other stockholder equity 17358.65M 17473.34M 16857.80M 1538.72M 1434.78M
Property plant equipment 29.64M 74.01M 28.55M 10.30M 10.15M
Total current assets 1315.39M 1225.44M 1059.61M 588.00M 532.74M
Long term investments - - - - -
Net tangible assets -556.08600M -368.69500M -665.24700M 67.49M 28.53M
Short term investments 0.00000M 2.54M 53.24M 2.71M 54.55M
Net receivables 210.55M 168.96M 169.28M 56.95M 43.57M
Long term debt 1535.29M 1225.67M 1379.59M 440.41M 414.68M
Inventory 56.34M 73.08M 56.50M - -
Accounts payable 47.69M 47.26M 46.03M 9.07M 7.77M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -42.77600M -6.28500M 18.52M -17.23900M -13.07000M
Additional paid in capital - - - - -
Common stock total equity 0.16M 0.16M 0.15M 0.07M 0.07M
Preferred stock total equity - - - - -
Retained earnings total equity -15008.28700M -1421.45400M -992.66100M -507.52500M -408.66100M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 48.54M 20.70M 18.36M 6.54M 1.40M
Deferred long term asset charges - - - - -
Non current assets total 3029.97M 16509.17M 16695.67M 1014.83M 996.14M
Capital lease obligations 38.04M 41.77M 43.14M 30.08M -
Long term debt total 1535.29M 1225.67M 1379.59M 440.41M 414.68M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 2.51M 60.90M 2.50M 47.10M 27.82M
Change to liabilities 5.03M 21.74M -37.78500M 6.09M 8.83M
Total cashflows from investing activities -167.74300M -72.98100M -590.97500M 25.01M -257.49600M
Net borrowings -3.14700M -0.91400M 965.93M 850.87M 279.16M
Total cash from financing activities 6.50M 40.95M 859.14M 35.09M 645.61M
Change to operating activities -31.24600M -35.06200M 25.58M 14.82M 10.19M
Net income -13659.53100M -428.79300M -485.13600M -98.86400M -97.08400M
Change in cash 24.70M 160.16M 218.97M 90.36M 381.17M
Begin period cash flow 893.48M 733.32M 514.35M 423.99M 42.82M
End period cash flow 918.18M 893.48M 733.32M 514.35M 423.99M
Total cash from operating activities 189.29M 193.99M -53.51100M 29.87M -4.86000M
Issuance of capital stock - - - 0.00000M 330.84M
Depreciation 270.64M 219.62M 78.09M 44.95M 35.60M
Other cashflows from investing activities -153.77000M 8.71M -589.44700M -18.57700M -281.30800M
Dividends paid - - - - -
Change to inventory 14.80M -19.49400M -24.73200M 10.28M 1.71M
Change to account receivables -61.64100M -17.51000M -21.09100M -15.88400M -10.93100M
Sale purchase of stock 12.38M 42.59M 59.04M 36.66M 364.73M
Other cashflows from financing activities 0.61M 41.09M 1097.29M 35.09M 314.77M
Change to netincome 13635.81M 453.49M 399.73M 58.50M 38.27M
Capital expenditures 172.76M 63.93M 26.04M 10.90M 8.41M
Change receivables -61.64100M -17.51000M -21.09100M -15.88400M -10.93100M
Cash flows other operating -1.19500M 84.29M 46.00M 80.02M 20.45M
Exchange rate changes - - - - -2.08400M
Cash and cash equivalents changes 28.05M 161.96M 214.65M 89.98M 381.17M
Change in working capital -60.97100M -50.32400M -90.48300M -0.15600M -1.13000M
Stock based compensation 217.85M 302.59M 475.53M 66.70M 43.77M
Other non cash items 13429.14M 109.10M 58.65M 28.10M 16.23M
Free cash flow 16.53M 130.06M -79.55300M 18.97M -13.26700M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TDOC
Teladoc Inc		 0.27 5.09% 5.57 - 357.14 1.36 1.48 1.53 -1.0757
GEHC
GE HealthCare Technologies Inc.		 -2.9 3.83% 72.73 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 -5.88 3.01% 189.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 11.42 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.07 1.34% 5.17 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Teladoc Inc

2 Manhattanville Road, Purchase, NY, United States, 10577

Key Executives

Name Title Year Born
Mr. Jason Nathanial Gorevic CEO & Director 1972
Ms. Mala Murthy Chief Financial Officer 1964
Mr. Adam Christian Vandervoort Chief Legal Officer & Sec. 1975
Mr. Andrew Turitz Sr. VP of Corp. Devel. 1973
Mr. Claus Torp Jensen Ph.D. Chief Innovation Officer NA
Dr. George Byron Brooks Co-Founder NA
Mr. Mike Waters Chief Operating Officer NA
Mr. Richard J. Napolitano Sr. VP, Chief Accounting Officer & Controller 1967
Mr. Patrick Thomas Feeley C.F.A., CPA VP of Investor Relations NA
Ms. Courtney Kraemer McLeod Director of Communication NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.